BPC:CSE, The Precision Peptide Company Inc.

Why BPC stock rose on November 17

The Precision Peptide Company Inc. rose 17.4% on Tuesday, November 17, 2026, on 200,000 shares. The headline around the move:

BPC stock overview

The Precision Peptide Company Inc. (BPC:CSE) closed at $0.225 on November 19, 2026, down 6.25% on the day. The stock trades 61.2% below its 52-week high of $0.580 and 28.6% above its 52-week low of $0.175. Over the past year, it lost 42.3%. The Precision Peptide Company Inc. is part of the Consumer Staples sector.

Key figures

Price
$0.225
Day change
-6.25%
Volume
32,236
Average volume
129,648
Market cap
12M+
52-week range
$0.175 – $0.580
50-day average
$0.343
200-day average
$0.404

Price action over the past year

In 252 trading sessions since November 19, 2025, BPC closed higher on 98 days (39%). Its best day was February 13, 2026 (+29.27%) and its worst was December 10, 2025 (-16.67%). The stock moved 10% or more in a single session 27 times.

Recent signals

BPC news

About The Precision Peptide Company Inc.

Pangea Wellness Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.

Similar stocks

Find more stocks like BPC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.